A B S T R A C T Pi phenotypes of alpha-1-protease inhibitor were determined by isoelectric focusing and print immunofixation in 96 English children suffering from juvenile chronic polyarthritis. A significantly increased frequency of the MZ phenotype (10.41%) was found in comparison with a geographically matched control population (1.6%). The results of this study suggest that the possession of a Z-deficient allele of alpha-l-protease inhibitor could be a predisposing, aggravating, or perpetuating factor in the articular damage occurring in juvenile chronic polyarthritis.
INTRODUCTION
The breakdown of articular collagen is an important feature of arthritic joint damage (1) , and this in part appears to be due to an increased activity of synovial collagenases (2, 3) . Alpha-l-protease inhibitor (AlPi,l formerly alpha-l-antitrypsin) is known to inhibit a variety of proteases, including human granulocyte collagenase (4) and elastase (5) , and it is possible that deficient activity of this protease inhibitor could be a predisposing, aggravating, or perpetuating factor in the pathophysiology of joint damage. The AlPi system is polymorphic, and its various phenotypes (Pi types) are determined by two autosomal codominant genes in each individual (6) . A certain number of the 25 alleles described to date are associated with decreased serum concentrations of AlPi. Perhaps the most important of these is the Z allele, the possession of which is associated with AlPi serum concentrations of only 20% of normal as well as with several clinical disorders such as pulmonary emphysema (7) and liver diseases (8) . An increased frequency of Z phenotypes has been reported recently in adults with rheumatoid arthritis (9) . We have investigated the hypothesis that deficient alleles may also be more common in children with juvenile chronic polyarthritis (JCP).
METHODS
We studied 96 English Caucasian patients with JCP referred to the British Medical Research Council's Rheumatism Unit at Taplow, England. The criteria for the diagnosis were as defined by Ansell (10) : (a) onset before age 16; (b) involvement of four or more joints for at least 3 mo with pain and/or swelling and/or limitation of movements; (c) if fewer joints are involved, histology showing changes compatible with rheumatoid arthritis; and (d) exclusion of other disorders in the 1st yr of disease, including ankylosing spondylitis, psoriasis, ulcerative colitis, and systemic lupus erythematosus. At the time of the blood sample, the mean age of these 96 patients was 5.4 yr (9 mo-15 yr) and the male:female ratio was 2:7 (26 male, 70 female). 20 had presented with a systemic illness going on to polyarthritis, chronic iridocyclitis was present in 35, and amyloidosis in 20. A small number of cases had more than one of these features; i.e., two with chronic iridocyclitis also had amyloidosis. In 58 cases we also examined sera from the patient's father and mother, and parentage in each case was confirmed by Gm, Am, Inv, and HLA typing.
Sera were obtained following informed consent and stored at -20°C until tested. AlPi phenotypes were determined using analytical thin-layer isoelectric focusing as previously 
RESULTS
The distribution of AlPi phenotypes in JCP (Table  I) was compared with that found in controls from the same geographical region (15) . The frequency of the MZ phenotype was significantly higher in the study group than in controls (P < 0.001). The frequency of the MS phenotype was also elevated, although this difference was not statistically significant. The distribution of the other phenotypes did not differ appreciably from control values. In 58 cases the parental phenotypes of AlPi were also studied. In the case of S and Mc alleles, inheritance in random fashion equally from mother and father was observed (Table II) , supporting the concept of autosomal codominant transmission (6) . In contrast, the Z allele appeared to be transmitted to the patient from the father in all but one case (Table II) . DISCUSSION The striking finding in this study is the increased prevalence of Z phenotypes in JCP. This is an important observation, since AlPi is known to inhibit the activity of collagenases and neutral proteases, which are found in increased amounts in arthritic joints (2, 16) , and levels of AlPi in synovial fluids appear to be elevated in parallel (17) . In patients with deficient phenotypes, the serum level of AlPi is reduced, and since this level parallels the amount found in synovial fluid (17), the latter would be expected to be markedly reduced. Since the mechanism of inhibition of proteolytic activity involves formation of complexes between AlPi and proteases (18) (19) (20) , low levels of AlPi could result in increased amounts of protease remaining unbound and active. Furthermore, we have shown that such unbound proteases can act upon formed complexes causing denaturation of AlPi. This leads to dissociation of the complexes and the release of the previously inactivated protease in a form which is biologically active.2 The increase in S allele frequency, although not significant, may have similar significance since this allele is also associated with decreased amounts (20%) of serum AlPi (21) . The clinical relevance of the increase in Pi-deficient phenotypes is not clear. No differences in distribution of Pi types were apparent when patients were subdivided with respect to clinical complications such as amyloidosis, systemic involvement, and iridocyclitis, although the frequency of S phenotypes was high in patients who had developed amyloid. Similarly, an influence of deficient phenotypes on the age of disease onset was not evident in our study, and we did not find any significant association between Pi alleles and other genetic markers (Gm, Am, Inv, HLA).
Following the previous report by Cox and Huber (9) of adult patients with rheumatoid arthritis, JCP is now the second rheumatic disorder in which an elevated frequency of deficient phenotypes of AlPi has been reported. Clearly, investigation of other disease groups may reveal additional examples, and it would also be important to investigate persons with deficient phenotypes of AlPi to determine the frequency of rheumatic disorders. Determination of Pi types may prove in the future to be useful in genetic counseling, as well as in the diagnosis, management, and prognosis of patients with rheumatic disorders, and may provide further information concerning the pathogenesis and transmission of these diseases.
